The FDA on Nov. 11 appointed Richard Pazdur, MD, as the new director of the Center for Drug Evaluation and Research.
Pazdur joined the FDA in 1999 and recently served as founding director of the Oncology Center of Excellence.
“I’m honored to lead the CDER at a time when the FDA is achieving long-sought regulatory reforms,” Pazdur said in an agency press release. “I look forward to working closely with [FDA commissioner Marty Makary, MD, MPH,] and the medical experts he’s assembled to help our country reach its peak in drug development.”
Pazdur replaces George F. Tidmarsh, MD, PhD, who resigned